NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) on behalf of TransMedics stockholders. Our investigation concerns whether TransMedics has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

TransMedics shares fell more than 9% on Monday, February 26, after Canaccord Genuity issued a note flagging "potential risk" to the company following receipt of a letter from Representative Paul Gosar accusing the company of, among other things, misappropriating corporate resources, and a Washington Post report regarding a federal investigation of organ transplant organizations. TransMedics developed the FDA-approved Organ Care System.

If you purchased or otherwise acquired TransMedics shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com